Bionomics Total Liab from 2010 to 2024

BNOX Stock  USD 0.30  0.02  7.14%   
Bionomics Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities is likely to outpace its year average in 2024. Total Liabilities is the total amount of all liabilities that Bionomics Ltd ADR has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2001-06-30
Previous Quarter
10.2 M
Current Value
5.8 M
Quarterly Volatility
12.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Total Liab Growth Pattern

Below is the plot of the Total Liab of Bionomics Ltd ADR over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Bionomics' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Pretty Stable
   Total Liab   
       Timeline  

Bionomics Total Liab Regression Statistics

Arithmetic Mean17,374,852
Geometric Mean11,967,085
Coefficient Of Variation73.37
Mean Deviation10,984,681
Median13,272,369
Standard Deviation12,747,919
Sample Variance162.5T
Range36.4M
R-Value(0.14)
Mean Square Error171.7T
R-Squared0.02
Significance0.62
Slope(394,742)
Total Sum of Squares2275.1T

Bionomics Total Liab History

202413.3 M
202310.2 M
20226.6 M
20215.8 M
2020M
201915 M
201826.1 M

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities10.2 M13.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.